Healius Limited

As of June 30, 2025, Healius Limited carries a market capitalization of 570.01M, placing it among publicly traded companies globally. Its enterprise value stands at 1.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Healius Limited's next confirmed earnings release is scheduled for February 24, 2027.

As of June 30, 2025, Healius Limited has 726.13M shares outstanding.

These figures are as of June 30, 2025. The price-to-sales ratio is 0.42, and the price-to-book ratio stands at 0.97.

These figures are as of June 30, 2025. The EV/Sales ratio of 1.06 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.42B versus a market cap of 570.01M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2025, Healius Limited maintains a current ratio of 0.56, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 155.09, indicating elevated leverage, while an interest coverage ratio of -10.70 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2025, Healius Limited posted a negative return on equity (ROE) of -18.57, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -6.35, reflecting losses generated across the asset base. The company generates approximately 168,025.00 in revenue per employee across its workforce of 8,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.94 indicates how many times Healius Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2025, Healius Limited recorded an income tax benefit of -29.10M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -592.10M and -151.20M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Healius Limited's stock has declined approximately 47.13% over the past 52 weeks. The 50-day moving average sits at 0.42, while the 200-day moving average is 0.51.

Over the twelve months ended June 30, 2025, Healius Limited generated 1.34B in revenue and converted that into -151.20M in net income, yielding earnings per share of -0.78. EBITDA reached -281.50M, while operating income came in at 200,000.00.

As of June 30, 2025, Healius Limited holds 57.20M in cash and equivalents against 911.80M in total debt, resulting in a net debt position of -57.20M. Total book value stands at 587.90M, with working capital of -194.30M providing operational flexibility.

These figures cover the twelve months ended June 30, 2025.

Over the twelve months ended June 30, 2025, Healius Limited posted a gross margin of 84.08, reflecting its pricing power and cost economics. The operating margin of 0.01 and net profit margin of -11.25 provide insight into operational efficiency.

Over the twelve months ended June 30, 2025, Healius Limited paid dividends of 0.41 per share. The dividend payout ratio of -53.27 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 178.70, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Healius Limited shareholders.

Healius Limited's most recent stock split took place on November 22, 2023 with a 199:215 split ratio.

As of June 30, 2025, Healius Limited has an Altman Z-Score of -1.04, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.